Unusual Options Activity In Amarin

Five months ago I talked about Amarin and their Vascepa drug,

Amarin…A Potential 5X Bagger With Fish Oil

Vascepa, a drug derived from fish oil, has been on the market in the U.S. since 2012, but has only managed about $100 million in sales for in 2018 thus far. However, the results obtained last week, opens up a whole new market for the Vascepa. Amarin has suggested that Vascepa could now generate up $2 billion in sales.

Vascepa is the only fish-oil product of its kind on the market, costing only $1500/yr, but as low as $3 / month with insurance.

About the author: TIMM Trader

Uniting Experts & Novices for Mutual Profit!